Journal of Gene Medicine

J Gene Med

1099-498X

1521-2254

Therapeutic Area

Biotechnology, Genomics, Molecular Medicine, Neurology, Oncology, Research, Vaccines/Vaccinology

Microbiologists, Molecular Biologists, Neurologists, Oncologists, Pharmacologists, Researchers, Scientists

The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies. Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials. Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.

Australasian Gene and Cell Therapy Society (AGCTS), Japan Society of Gene Therpy (JSGT)

John Wiley & Sons Ltd. - UK

Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Frequency Journal Contact Author Submission Guidelines